Evidence map›Paper›PMID 38810864›Full record

ArticleAmerican journal of ophthalmology2024

Frequency of Agreement Between Structural and Functional Glaucoma Testing: A Longitudinal Study of 3D OCT and Current Clinical Tests.

Dhruv Manik, Kitiya Ratanawongphaibul, Janice Kim, Edem Tsikata, Hang Lee, Milica A Margeta, Courtney L Ondeck, Johannes F De Boer, Teresa C Chen

Abstract readComparative Study
In one paragraph

Article in American journal of ophthalmology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Dhruv ManikFrom the Boston University Chobanian & Avedisian School of Medicine (D.M.), Boston, Massachusetts, USA; Department of Ophthalmology, Glaucoma Service, Massachusetts Eye and Ear (D.M., K.R., J.K., E.T., M.A.M., C.L.O., T.C.C.), Boston, Massachusetts, USA; Harvard Medical School (D.M., K.R., J.K., E.T., H.L., M.A.M., C.L.O., T.C.C.), Boston, Massachusetts, USA.
Kitiya RatanawongphaibulDepartment of Ophthalmology, Glaucoma Service, Massachusetts Eye and Ear (D.M., K.R., J.K., E.T., M.A.M., C.L.O., T.C.C.), Boston, Massachusetts, USA; Harvard Medical School (D.M., K.R., J.K., E.T., H.L., M.A.M., C.L.O., T.C.C.), Boston, Massachusetts, USA; Center of Excellence in Glaucoma, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society (K.R.), Bangkok, Thailand.
Janice KimDepartment of Ophthalmology, Glaucoma Service, Massachusetts Eye and Ear (D.M., K.R., J.K., E.T., M.A.M., C.L.O., T.C.C.), Boston, Massachusetts, USA; Harvard Medical School (D.M., K.R., J.K., E.T., H.L., M.A.M., C.L.O., T.C.C.), Boston, Massachusetts, USA.
Edem TsikataDepartment of Ophthalmology, Glaucoma Service, Massachusetts Eye and Ear (D.M., K.R., J.K., E.T., M.A.M., C.L.O., T.C.C.), Boston, Massachusetts, USA; Harvard Medical School (D.M., K.R., J.K., E.T., H.L., M.A.M., C.L.O., T.C.C.), Boston, Massachusetts, USA.
Hang LeeHarvard Medical School (D.M., K.R., J.K., E.T., H.L., M.A.M., C.L.O., T.C.C.), Boston, Massachusetts, USA; Massachusetts General Hospital Biostatistics Center, Department of Medicine, Massachusetts General Hospital (H.L.), Boston, Massachusetts, USA.
Milica A MargetaDepartment of Ophthalmology, Glaucoma Service, Massachusetts Eye and Ear (D.M., K.R., J.K., E.T., M.A.M., C.L.O., T.C.C.), Boston, Massachusetts, USA; Harvard Medical School (D.M., K.R., J.K., E.T., H.L., M.A.M., C.L.O., T.C.C.), Boston, Massachusetts, USA.
Courtney L OndeckDepartment of Ophthalmology, Glaucoma Service, Massachusetts Eye and Ear (D.M., K.R., J.K., E.T., M.A.M., C.L.O., T.C.C.), Boston, Massachusetts, USA; Harvard Medical School (D.M., K.R., J.K., E.T., H.L., M.A.M., C.L.O., T.C.C.), Boston, Massachusetts, USA; Department of Ophthalmology, VA Boston Hospital (C.L.O.), Boston, Massachusetts, USA.
Johannes F De BoerLaserLaB Amsterdam, Department of Physics and Astronomy, Vrijie Universiteit (J.F.D.B.), Amsterdam, The Netherlands; Department of Ophthalmology, Vrijie Universiteit Medical Center (J.F.D.B.), Amsterdam, The Netherlands.
Teresa C ChenDepartment of Ophthalmology, Glaucoma Service, Massachusetts Eye and Ear (D.M., K.R., J.K., E.T., M.A.M., C.L.O., T.C.C.), Boston, Massachusetts, USA; Harvard Medical School (D.M., K.R., J.K., E.T., H.L., M.A.M., C.L.O., T.C.C.), Boston, Massachusetts, USA. Electronic address: Teresa_chen@meei.harvard.edu.

Funding

HARVARD CLINICAL AND TRANSLATIONAL SCIENCE CENTER (UL1)UL1RR025758 · NCRR · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2008 to 2011
$91.4M
Mass Eye and Ear-Vision Clinical Scientist Development ProgramK12EY016335 · NEI · MASSACHUSETTS EYE AND EAR INFIRMARY · PI Reza Dana · 2004 to 2026
$12.3M
Glaucoma Drainage Device and Endothelial Cell Density Loss Compare (DECLARE) TrialUG1EY033703 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Ying Han, Jennifer Rose-Nussbaumer · 2023 to 2026
$4.4M
Universal optical coherence polarimetryR01EB033321 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI VILLIGER, MARTIN · 2022 to 2025
$2.0M
Ultra-high speed AO-OCT clinical system to image ganglion cells and microgliaR44EY034409 · NEI · PHYSICAL SCIENCES, INC · PI MUJAT, MIRCEA · 2022 to 2023
$1.7M
The Role of APOE Signaling in Microglia in GlaucomaK08EY030160 · NEI · MASSACHUSETTS EYE AND EAR INFIRMARY · PI MARGETA, MILICA · 2019 to 2021
$703k
NCRR NIH HHS UL1 RR025758NEI NIH HHS K08 EY030160NEI NIH HHS K12 EY016335NEI NIH HHS R44 EY034409NEI NIH HHS UG1 EY033703NIBIB NIH HHS R01 EB033321
6 · The paper itself

Abstract

purposeTo evaluate how often tests of structure and function detect glaucoma progression at the same study visit. Tests include current glaucoma clinical tests and a new 3-dimensional (3D) optical coherence tomography (OCT) rim measurement.

designProspective cohort study.

methodsFor 124 open-angle glaucoma patients at a single institution, one eye was randomly selected for each patient. Patients were included if they had open-angle glaucoma and if they had at least 4 yearly study visits. Study visits included a full dilated eye exam, disc photography (DP), Humphrey visual field (HVF 24-2) testing, 2D OCT retinal nerve fibre layer (RNFL) thickness measurements, and 3D OCT neuroretinal rim measurements (i.e., minimum distance band or MDB). For each test at each study visit, eyes were classified as progressors or non-progressors using event-based analysis. Agreement occurred if tests progressed in the same eye at the same study visit. Agreements between all compared tests were calculated as percentages of agreement.

resultsThe study included 124 open-angle glaucoma eyes, which had an average follow-up period of 66.9 ± 16.4 months. Structural tests (i.e., DP, global RNFL thickness, and global MDB rim thickness) progressed at the same visit as the functional test (i.e., HVF testing) in only 5.0% (3/60) to 16.0% (13/81) of eyes. Global MDB thickness and global RNFL thickness showed similar agreement with functional HVF testing (i.e., 16.0% [13/81] and 8.3% [7/84], respectively), and global MDB thickness showed better structure-function agreement with HVF testing than between DP and HVF testing (i.e., 5.0% [3/60], P = 0.04). For all paired comparisons between testing methods, eyes with moderate glaucoma showed similar or better agreement than eyes with mild or severe glaucoma.

conclusionsClinical tests of structure and function do not usually progress at the same clinic visit. Most of the time, glaucoma progression is only detected by one or two tests.

Indexed as

Disease ProgressionGlaucoma, Open-AngleImaging, Three-DimensionalIntraocular PressureNerve FibersOptic DiskOptic Nerve DiseasesRetinal Ganglion CellsTomography, Optical CoherenceVisual FieldsVisual Field TestsAgedFemaleFollow-Up StudiesHumansMale

Identifiers

PMID38810864
PMCPMC11402569

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.